BIOCON - Biocon Limited
Biocon Limited Share Market Related News
-: Stock News :- BIOCON 07-06-2022 To 07-06-2022
✔️ Biocon chief Kiran Majumdar-Shaw slams poor condition of Bengaluru roads
-: Stock News :- BIOCON 19-05-2022 To 19-05-2022
✔️ CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics
✔️ Biocon Biologics, Viatris, launch Abevmy in Canada
✔️ Biocon Biologics and Viatris launch their third oncology biosimilar in Canada
-: Stock News :- BIOCON 19-05-2022 To 18-05-2022
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
-: Stock News :- BIOCON 03-05-2022 To 18-05-2022
✔️ Ireland regulator reports manufacturing deficiency at Biocon's plant
✔️ Ireland regulator reports manufacturing deficiency at Biocon's Bengaluru plant
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
-: Stock News :- BIOCON 30-04-2022 To 30-04-2022
✔️ Buy Biocon: target of Rs 420: Sharekhan
✔️ Neutral Biocon; target of Rs 410: Motilal Oswal
✔️ Hold Biocon; target of Rs 380: ICICI Direct
-: Stock News :- BIOCON 29-04-2022 To 28-04-2022
✔️ Biocon Biologics expects R&D expenses to hover between 10-15% in the next financial year
✔️ Encouraged by strong performance', says Kiran Mazumdar-Shaw on Biocon Q4 results
✔️ Biocon's March Quarter Profit Falls 4% To Rs 283 Crore
✔️ Biocon Q4 consolidated net profit declines by 4% to Rs 283 crore
-: Stock News :- BIOCON 26-04-2022 To 26-04-2022
✔️ Biocon Biologics bags $90 million contract from Malaysia govt
✔️ Biocon arm signs $90 million contract with Malaysia for human insulin brand Insugen
✔️ Biocon's arm gets $90 mn contract from Malaysian government for insulins
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
-: Stock News :- BIOCON 29-03-2022 To 26-04-2022
✔️ Glasgow Uni names research centre after John Shaw and Kiran Mazumdar-Shaw
✔️ Biocon arm signs $90 million contract with Malaysia for human insulin brand Insugen
✔️ Biocon's arm gets $90 mn contract from Malaysian government for insulins
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
-: Stock News :- BIOCON 23-03-2022 To 26-04-2022
✔️ Kiran Mazumdar-Shaw elected as fellow of Royal Society of Edinburgh
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
-: Stock News :- BIOCON 04-03-2022 To 26-04-2022
✔️ Hold Biocon; target of Rs 390: ICICI Direct
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
-: Stock News :- BIOCON 02-03-2022 To 26-04-2022
✔️ Biocon chief says India can help Biden fulfill his affordable insulin promise
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
-: Stock News :- BIOCON 01-03-2022 To 27-02-2022
✔️ Post Viatris deal, eyes on execution for Biocon
✔️ Buy Biocon: target of Rs 420: Sharekhan
✔️ Neutral Biocon; target of Rs 385 : Motilal Oswal
✔️ Biocon's unit buys biosimilar assets of Viatris for $3.34 billion
✔️ Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 12-02-2022 To 27-02-2022
✔️ Rahul Bajaj Passes Away: Corporates, Political Leaders Express Grief
✔️ Buy Biocon: target of Rs 420: Sharekhan
✔️ Neutral Biocon; target of Rs 385 : Motilal Oswal
✔️ Biocon's unit buys biosimilar assets of Viatris for $3.34 billion
✔️ Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 08-02-2022 To 27-02-2022
✔️ Biocon gains 3%, at 6-month high in a weak market; stock up 18% in 3 weeks
✔️ Buy Biocon: target of Rs 420: Sharekhan
✔️ Neutral Biocon; target of Rs 385 : Motilal Oswal
✔️ Biocon's unit buys biosimilar assets of Viatris for $3.34 billion
✔️ Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 27-01-2022 To 27-02-2022
✔️ Accumulate BIOCON; target of Rs 422: Hem Securities
✔️ Buy Biocon: target of Rs 420: Sharekhan
✔️ Neutral Biocon; target of Rs 385 : Motilal Oswal
✔️ Biocon's unit buys biosimilar assets of Viatris for $3.34 billion
✔️ Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 24-01-2022 To 27-02-2022
✔️ Insulins access program for young expanded in Dec quarter: Biocon Biologics MD
✔️ Biocon Consolidated December 2021 Net Sales at Rs 2,174.20 crore, up 17.46% Y-o-Y
✔️ Neutral Biocon; target of Rs 385 : Motilal Oswal
✔️ Biocon's unit buys biosimilar assets of Viatris for $3.34 billion
✔️ Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 21-01-2022 To 27-02-2022
✔️ Q3FY22 Quarterly Result Announced for Biocon Ltd.
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 19-01-2022 To 27-02-2022
✔️ Biocon share price surges after Morgan Stanley upgrades stock to 'outperform'
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 18-01-2022 To 27-02-2022
✔️ COVID-19: Would like to give booster doses to all employees', says Kiran Mazumdar-Shaw
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 07-01-2022 To 27-02-2022
✔️ USFDA rejects Biocon, Viatris application for Insulin Aspart
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 04-01-2022 To 27-02-2022
✔️ Biocon announces merger of its arm with Serum Institute subsidiary
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 30-12-2021 To 27-02-2022
✔️ Biocon Biologics partner Viatris wins favourable order from US court
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 20-12-2021 To 27-02-2022
✔️ Can booster doses prevent new variants? Here's what Kiran Mazumdar-Shaw has to say
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 07-12-2021 To 27-02-2022
✔️ Why Biocon's earnings to get a boost after two muted years
✔️ Biocon ties up with Saudi drug firm Tabuk to commercialise speciality medicines
✔️ Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 02-12-2021 To 27-02-2022
✔️ Biocon gets USFDA nod for generic product
✔️ Biocon gets USFDA nod for generic product
✔️ Biotechnology major Biocon gets USFDA approval for generic product
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 01-12-2021 To 27-02-2022
✔️ Even if you don't have COVID...: Biocon chief on 6-hr wait at airports amid Omicron threat
✔️ Biocon to be listed on DJSI in Emerging Markets category
✔️ Biocon enters Dow Jones Sustainability Index in Emerging Markets category
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 21-11-2021 To 27-02-2022
✔️ A turnaround for Biocon likely post Semglee launch
✔️ Biocon to be listed on DJSI in Emerging Markets category
✔️ Biocon enters Dow Jones Sustainability Index in Emerging Markets category
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 19-11-2021 To 27-02-2022
✔️ Biocon Biologics, Viatris confirm offering steep savings on long-acting insulin through Walgreens Prescription Savings Club
✔️ Biocon to be listed on DJSI in Emerging Markets category
✔️ Biocon enters Dow Jones Sustainability Index in Emerging Markets category
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 16-11-2021 To 27-02-2022
✔️ Biocon launches inter-changeable biosimilar insulin in US
✔️ Biocon Biologics, Viatris launch biosimilar insulin glargine in US
✔️ Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 15-11-2021 To 27-02-2022
✔️ Biocon starts campaign to treat diabetic children, train healthcare workers
✔️ Biocon Biologics, Viatris launch biosimilar insulin glargine in US
✔️ Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 09-11-2021 To 27-02-2022
✔️ Covid reinforced global dependence on Indian IT sector: Kris Gopalakrishnan
✔️ Biocon Biologics, Viatris launch biosimilar insulin glargine in US
✔️ Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 26-10-2021 To 27-02-2022
✔️ Serum alliance will help margins from H2 of FY23: Biocon Biologics dy CEO
✔️ Biocon Biologics, Viatris launch biosimilar insulin glargine in US
✔️ Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 25-10-2021 To 27-02-2022
✔️ Buy Biocon: target of Rs 470: Sharekhan
✔️ Biocon Biologics, Viatris launch biosimilar insulin glargine in US
✔️ Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 22-10-2021 To 27-02-2022
✔️ Q2FY22 Quarterly Result Announced for Biocon Ltd.
✔️ Biocon share price falls 5% after Q2 profit dips to Rs 138 crore
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon net rises 11% in Q2 to Rs 188 cr, revenue up 10% at Rs 1,945 cr
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 21-10-2021 To 27-02-2022
✔️ Biocon's insulin biosimilar Glargine gets preference in top US formulary
✔️ Biocon share price falls 5% after Q2 profit dips to Rs 138 crore
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon net rises 11% in Q2 to Rs 188 cr, revenue up 10% at Rs 1,945 cr
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 05-10-2021 To 27-02-2022
✔️ Pandora Papers: 'Kunal Kashyap has no influence over Biocon-linked trust'
✔️ Biocon share price falls 5% after Q2 profit dips to Rs 138 crore
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon net rises 11% in Q2 to Rs 188 cr, revenue up 10% at Rs 1,945 cr
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 04-10-2021 To 27-02-2022
✔️ Kiran Mazumdar-Shaw says husband's offshore trust wrongly implicated
✔️ Decoded: Of 'Pandora Papers', insider trading and Biocon link
✔️ Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
✔️ Biocon share price gains on launch of cancers drug in the US market
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 27-09-2021 To 27-02-2022
✔️ Biocon gets 6 observations from USFDA for its Malaysian facility in pre-approval inspection
✔️ Decoded: Of 'Pandora Papers', insider trading and Biocon link
✔️ Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
✔️ Biocon share price gains on launch of cancers drug in the US market
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 25-09-2021 To 27-02-2022
✔️ USFDA issues six observations post inspection of Biocon's Malaysian arm manufacturing facility
✔️ USFDA issues six observations after inspection of Biocon's Malaysian arm manufacturing facility
✔️ Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
✔️ Biocon share price gains on launch of cancers drug in the US market
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 23-09-2021 To 27-02-2022
✔️ Industry says UK's non-recognition of Indian vaccine certificates unfair'
✔️ USFDA issues six observations after inspection of Biocon's Malaysian arm manufacturing facility
✔️ Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
✔️ Biocon share price gains on launch of cancers drug in the US market
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 20-09-2021 To 27-02-2022
✔️ Can Serum deal provide a booster dose to Biocon's target price?
✔️ Vaccine access, biosimilars growth to boost Biocon's earnings outlook
✔️ Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
✔️ Biocon share price gains on launch of cancers drug in the US market
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 17-09-2021 To 27-02-2022
✔️ Biocon-Serum alliance to build a global biotech powerhouse, say Kiran Mazumdar-Shaw, Adar Poonawalla
✔️ Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
✔️ The daily dose: September 17, 2021
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn
✔️ Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 08-09-2021 To 27-02-2022
✔️ Biocon inks patent litigation settlement pact with Celgene
✔️ Revlimid drug: Biocon enters patent litigation settlement with Celgene
✔️ The daily dose: September 17, 2021
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn
✔️ Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 07-09-2021 To 27-02-2022
✔️ India to take 9 more months for full vaccination; avoid congregations: Shaw
✔️ Revlimid drug: Biocon enters patent litigation settlement with Celgene
✔️ The daily dose: September 17, 2021
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn
✔️ Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 30-07-2021 To 27-02-2022
✔️ The daily dose: July 30, 2021
✔️ Revlimid drug: Biocon enters patent litigation settlement with Celgene
✔️ The daily dose: September 17, 2021
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn
✔️ Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 29-07-2021 To 27-02-2022
✔️ Biocon, Viatris get USFDA's nod for interchangeable biosimilar product
✔️ Vaccines alone will not protect and make the world safer: Biocon chief
✔️ USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug
✔️ Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar product
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn
✔️ Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 27-07-2021 To 27-02-2022
✔️ Hold Biocon: target of Rs 400: ICICI Direct
✔️ Buy Biocon: target of Rs 470: Sharekhan
✔️ Coronavirus LIVE: Biocon joins Adagio for licence to make antibody cocktail
✔️ Biocon partners Adagio for licence to make Covid-19 antibody cocktail
✔️ US-based Adagio Therapeutics gives Biocon Biologics licence to make antibody treatment for Covid-19
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 23-07-2021 To 27-02-2022
✔️ Biocon net profit falls 35% to Rs 108 crore in Apr-Jun
✔️ Biocon Q1 net profit declines 35% to Rs 108.4 cr; revenue at Rs 1807.8 cr
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 01-07-2021 To 27-02-2022
✔️ Sebi bars Biocon's official from securities mkt for 3 months, levies fine
✔️ Biocon Q1 net profit declines 35% to Rs 108.4 cr; revenue at Rs 1807.8 cr
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 15-06-2021 To 27-02-2022
✔️ Covid has created an 'ecosystem' of innovation in India, says Biocon chief Kiran Mazumdar-Shaw
✔️ Covid has created an ecosystem of innovation in India: Kiran Mazumdar-Shaw
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 25-05-2021 To 27-02-2022
✔️ Hold Biocon: target of Rs 400: ICICI Direct
✔️ Covid has created an ecosystem of innovation in India: Kiran Mazumdar-Shaw
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 19-05-2021 To 27-02-2022
✔️ Sebi fines Biocon, its designated person for violating market norms
✔️ Covid has created an ecosystem of innovation in India: Kiran Mazumdar-Shaw
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 15-05-2021 To 27-02-2022
✔️ Biocon chief Kiran Mazumdar-Shaw compares COVID vaccination situation in India to arranged marriage
✔️ Biocon chief compares Covid vaccination in India to arranged marriage
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 12-05-2021 To 27-02-2022
✔️ Biocon perplexed' about Itolizumab not being in Covid protocol
✔️ Biocon chief compares Covid vaccination in India to arranged marriage
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 11-05-2021 To 27-02-2022
✔️ Biocon chief expresses concern over Covid-19 vaccine shortage
✔️ Biocon chief Kiran Mazumdar-Shaw expresses concern over Covid vaccine shortage
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 06-05-2021 To 27-02-2022
✔️ Covid second wave has hit India 'like a tsunami' says Kiran Mazumdar Shaw
✔️ Biocon chief Kiran Mazumdar-Shaw expresses concern over Covid vaccine shortage
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 03-05-2021 To 27-02-2022
✔️ Remdesivir supply issues might ease by third week of May: Biocon's Kiran Mazumdar-Shaw
✔️ Biocon chief Kiran Mazumdar-Shaw expresses concern over Covid vaccine shortage
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 02-05-2021 To 27-02-2022
✔️ Amid weak showing by biosimilars and generics, downgrade pressure on Biocon
✔️ Biocon chief Kiran Mazumdar-Shaw expresses concern over Covid vaccine shortage
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 30-04-2021 To 27-02-2022
✔️ Biocon Declines Over 3% After Net Profit Rose 105% In March Quarter
✔️ Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 26-04-2021 To 27-02-2022
✔️ Biocon Biologics, Viatris get EC nod for biosimilar drug Bevacizumab
✔️ Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 21-04-2021 To 27-02-2022
✔️ Demand spikes for Biocon's repurposed drug
✔️ Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 17-04-2021 To 27-02-2022
✔️ How to earn 13,000-profit with bull-call spread on Biocon
✔️ Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 12-04-2021 To 27-02-2022
✔️ Biocon Pharma gets GMP compliance certificate from MHRA
✔️ Biocon's arm gets GMP compliance certificate from UK's health regulator MHRA for Bengaluru facility
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 29-03-2021 To 27-02-2022
✔️ Biocon forms tie-up with Libbs Farmaceutica
✔️ Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 02-03-2021 To 27-02-2022
✔️ Biocon Biologics appoints Susheel Umesh as Chief Commercial Officer for emerging markets
✔️ Shreehas Tambe promoted as Deputy CEO of Biocon Biologics
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 01-03-2021 To 27-02-2022
✔️ Biocon Biologics, Viatris get CHMP nod for Abevmy
✔️ Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to Avastin
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 28-02-2021 To 27-02-2022
✔️ Companies 'feel betrayed' due to capping of Covid-19 vaccine price: Kiran Mazumdar Shaw
✔️ Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to Avastin
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 16-02-2021 To 27-02-2022
✔️ Centenary Celebrations of insulin: Biocon Biologics to partner with International Diabetes Federation
✔️ Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to Avastin
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 12-02-2021 To 27-02-2022
✔️ Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
✔️ Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 04-02-2021 To 27-02-2022
✔️ Biocon Biologics inks pact to expand access to its cancer biosimilars
✔️ Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 02-02-2021 To 27-02-2022
✔️ Neutral Biocon; target of Rs 385: Motilal Oswal
✔️ Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 01-02-2021 To 27-02-2022
✔️ Buy Biocon; target of Rs 470: Sharekhan
✔️ Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 28-01-2021 To 27-02-2022
✔️ Women's economic empowerment vital to tackle gender inequality: Biocon head
✔️ Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 25-01-2021 To 27-02-2022
✔️ Delay in award of tenders, higher entry barriers to new markets restricting growth: Kiran Mazumdar Shaw
✔️ Biocon share price falls 2% after CLSA retains sell on stock
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 22-01-2021 To 27-02-2022
✔️ Biocon stock slides on poor Q3 results, exit of biologics arm's MD
✔️ Christiane Hamacher quits as CEO of Biocon Biologics
✔️ Biocon Q3 net profit falls 19% to Rs 186.6 crore
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal
-: Stock News :- BIOCON 22-01-2021 To 21-01-2021
✔️ Biocon Q3 net profit falls 17% to Rs 169 crore, revenue up 7%
✔️ Biocon shares plunge 9% post Q3 results
✔️ Biocon Consolidated December 2020 Net Sales at Rs 1,851.00 crore, up 5.89% Y-o-Y
✔️ Biocon Standalone December 2020 Net Sales at Rs 456.10 crore, down 9.02% Y-o-Y
✔️ Biocon Shares Fall After Profit Declines In December Quarter
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 08-01-2021 To 21-01-2021
✔️ Biocon shares up 2% after ADQ pumps Rs 555 crore in subsidiary
✔️ Biocon gains 2% after arm gets Rs 555 crore capital injection from ADQ
✔️ ADQ to buy 1.8% stake in Biocon arm for 555 cr
✔️ Abu Dhabi's ADQ to invest $75 mn in Biocon Biologics for 1.8% stake
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 29-12-2020 To 21-01-2021
✔️ Buy Biocon: target of Rs 520: Sharekhan
✔️ Biocon share price rises 2% on launch of Tacrolimus capsules in US
✔️ Biocon launches Tacrolimus capsules in US
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 28-12-2020 To 21-01-2021
✔️ Biocon: Street to keep an eye on CY21 launches, market share gains
✔️ Biocon share price rises 2% on launch of Tacrolimus capsules in US
✔️ Biocon launches Tacrolimus capsules in US
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 25-12-2020 To 21-01-2021
✔️ USFDA informs Biocon Biologics, Mylan of deferred action on Avastin biosimilar license application
✔️ USFDA informs Biocon, Mylan of deferred action on biosimilar license plea
✔️ Biocon launches Tacrolimus capsules in US
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 23-12-2020 To 21-01-2021
✔️ People who are infected should also take vaccine: Bharat Biotech Chairman
✔️ USFDA informs Biocon, Mylan of deferred action on biosimilar license plea
✔️ Biocon launches Tacrolimus capsules in US
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 15-12-2020 To 21-01-2021
✔️ Biocon Biologics inks pact with CSSC in Tanzania for its Mission 10 cents'
✔️ USFDA informs Biocon, Mylan of deferred action on biosimilar license plea
✔️ Biocon launches Tacrolimus capsules in US
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 14-12-2020 To 21-01-2021
✔️ Biocon Biologics gets CHMP market authorisation for rapid acting insulin
✔️ Biocon, Mylan's diabetic drug receives positive opinion from EMA panel
✔️ Biocon, Mylan's diabetic drug receives positive opinion from European Medicines Agency committee
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 04-12-2020 To 21-01-2021
✔️ Biocon may explore govt research initiatives for Itolizumab
✔️ Covid-19 vaccine: Biocon's US partner Equillium to withdraw Itolizumab trials
✔️ Biocon, Mylan's diabetic drug receives positive opinion from European Medicines Agency committee
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 03-12-2020 To 21-01-2021
✔️ Roshni Nadar tops Kotak Wealth and Hurun India's list of richest women
✔️ Covid-19 vaccine: Biocon's US partner Equillium to withdraw Itolizumab trials
✔️ Biocon, Mylan's diabetic drug receives positive opinion from European Medicines Agency committee
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 24-11-2020 To 21-01-2021
✔️ Hopefully DCGI to give nod for Oxford's vaccine immediately: Biocon chief
✔️ Biocon To Buy 26% Stake In Hinduja Renewables Two
✔️ Biocon to acquire 26% stake in Hinduja Renewables Two
✔️ Biocon to buy 26% stake in Hinduja Renewables Two
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 19-11-2020 To 21-01-2021
✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term
✔️ Biocon To Buy 26% Stake In Hinduja Renewables Two
✔️ Biocon to acquire 26% stake in Hinduja Renewables Two
✔️ Biocon to buy 26% stake in Hinduja Renewables Two
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 07-11-2020 To 21-01-2021
✔️ Biocon Biologics to raise $150 million from Goldman Sachs at $3.94 billion valuation
✔️ Biocon Biologics gets Rs 1,125 cr capital infusion from Goldman Sachs
✔️ Biocon to acquire 26% stake in Hinduja Renewables Two
✔️ Biocon to buy 26% stake in Hinduja Renewables Two
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 05-11-2020 To 21-01-2021
✔️ Biocon plans 2,000-crore capex for generics biz
✔️ Biocon Biologics gets Rs 1,125 cr capital infusion from Goldman Sachs
✔️ Biocon to acquire 26% stake in Hinduja Renewables Two
✔️ Biocon to buy 26% stake in Hinduja Renewables Two
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 30-10-2020 To 21-01-2021
✔️ Biocon's partner Equillium gets USFDA nod to begin phase-3 trial of itolizumab on COVID-19 patients
✔️ Biocon ranked among top five biotech employers globally
✔️ Biocon to acquire 26% stake in Hinduja Renewables Two
✔️ Biocon to buy 26% stake in Hinduja Renewables Two
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
-: Stock News :- BIOCON 23-06-2022 To 23-06-2022
✔️ Will bribery case impact Biocon's business? Expert weighs in
-: Stock News :- BIOCON 21-06-2022 To 20-06-2022
✔️ SEC recommendation in accordance with guidelines: Biocon Biologics
✔️ CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals
✔️ Biocon Biologics denies bribery charge; says it follows a strong code of conduct'
✔️ Biocon Biologics Denies Bribery Charge, Says Followed Regulations
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
-: Stock News :- BIOCON 20-06-2022 To 20-06-2022
✔️ Agnipath has job potential in corporate sector for youths: Industry leaders
✔️ CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals
✔️ Biocon Biologics denies bribery charge; says it follows a strong code of conduct'
✔️ Biocon Biologics Denies Bribery Charge, Says Followed Regulations
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
-: Stock News :- BIOCON 07-06-2022 To 20-06-2022
✔️ Biocon chief Kiran Majumdar-Shaw slams poor condition of Bengaluru roads
✔️ CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals
✔️ Biocon Biologics denies bribery charge; says it follows a strong code of conduct'
✔️ Biocon Biologics Denies Bribery Charge, Says Followed Regulations
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
-: Stock News :- BIOCON 19-05-2022 To 20-06-2022
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
✔️ Biocon Biologics Denies Bribery Charge, Says Followed Regulations
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
-: Stock News :- BIOCON 03-05-2022 To 20-06-2022
✔️ Ireland regulator reports manufacturing deficiency at Biocon's plant
✔️ Ireland regulator reports manufacturing deficiency at Biocon's Bengaluru plant
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
✔️ Biocon Biologics Denies Bribery Charge, Says Followed Regulations
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
-: Stock News :- BIOCON 30-04-2022 To 20-06-2022
✔️ Buy Biocon: target of Rs 420: Sharekhan
✔️ Neutral Biocon; target of Rs 410: Motilal Oswal
✔️ Hold Biocon; target of Rs 380: ICICI Direct
✔️ Biocon Biologics Denies Bribery Charge, Says Followed Regulations
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
-: Stock News :- BIOCON 29-04-2022 To 20-06-2022
✔️ Q4FY22 Quarterly Result Announced for Biocon Ltd.
✔️ Encouraged by strong performance', says Kiran Mazumdar-Shaw on Biocon Q4 results
✔️ Biocon's March Quarter Profit Falls 4% To Rs 283 Crore
✔️ Biocon Q4 consolidated net profit declines by 4% to Rs 283 crore
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
-: Stock News :- BIOCON 26-04-2022 To 20-06-2022
✔️ Biocon Biologics bags $90 million contract from Malaysia govt
✔️ Biocon arm signs $90 million contract with Malaysia for human insulin brand Insugen
✔️ Biocon's arm gets $90 mn contract from Malaysian government for insulins
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
-: Stock News :- BIOCON 29-03-2022 To 20-06-2022
✔️ Glasgow Uni names research centre after John Shaw and Kiran Mazumdar-Shaw
✔️ Biocon arm signs $90 million contract with Malaysia for human insulin brand Insugen
✔️ Biocon's arm gets $90 mn contract from Malaysian government for insulins
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
-: Stock News :- BIOCON 23-03-2022 To 20-06-2022
✔️ Kiran Mazumdar-Shaw elected as fellow of Royal Society of Edinburgh
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
-: Stock News :- BIOCON 04-03-2022 To 20-06-2022
✔️ Hold Biocon; target of Rs 390: ICICI Direct
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
-: Stock News :- BIOCON 02-03-2022 To 20-06-2022
✔️ Biocon chief says India can help Biden fulfill his affordable insulin promise
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection
-: Stock News :- BIOCON 06-07-2022 To 06-07-2022
✔️ Biocon arm Syngene ends contract with Bioinnovat Research over graft case
-: Stock News :- BIOCON 02-07-2022 To 02-07-2022
✔️ Centre suspends 3 scientists over fake Remdesivir sale in Covid 2nd wave
-: Stock News :- BIOCON 09-08-2022 To 09-08-2022
✔️ Biocon looks to shore up biosimilar business. Will its investment pay off?
-: Stock News :- BIOCON 04-08-2022 To 04-08-2022
✔️ SAT quashes insider trading charges against Biocon official Shreehas Tambe
-: Stock News :- BIOCON 29-07-2022 To 29-07-2022
✔️ We're geared to launch a new molecule every 1-2 years: Biocon Biologics MD
-: Stock News :- BIOCON 27-07-2022 To 27-07-2022
✔️ Biocon'sQ1 net profit up by 71 per cent to 144crore
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%
-: Stock News :- BIOCON 21-07-2022 To 27-07-2022
✔️ Biocon receives three US FDA observations on its Telangana plant
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%
-: Stock News :- BIOCON 06-07-2022 To 27-07-2022
✔️ Biocon arm Syngene ends contract with Bioinnovat Research over graft case
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%
-: Stock News :- BIOCON 02-07-2022 To 27-07-2022
✔️ Centre suspends 3 scientists over fake Remdesivir sale in Covid 2nd wave
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%
-: Stock News :- BIOCON 23-06-2022 To 27-07-2022
✔️ Will bribery case impact Biocon's business? Expert weighs in
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%
-: Stock News :- BIOCON 01-09-2022 To 01-09-2022
✔️ Biocon sheds 4%, hits 52-week low as US FDA issues form 483 for 3 sites
-: Stock News :- BIOCON 31-08-2022 To 31-08-2022
✔️ US FDA issues 11 observations each for two sites in Bengaluru: Biocon
-: Stock News :- BIOCON 25-08-2022 To 25-08-2022
✔️ CBI files charge sheet in Rs 9 lakh Biocon Biologics bribery case
✔️ CBI files charge sheet in Biocon case
-: Stock News :- BIOCON 09-08-2022 To 25-08-2022
✔️ Biocon looks to shore up biosimilar business. Will its investment pay off?
✔️ CBI files charge sheet in Biocon case
-: Stock News :- BIOCON 04-08-2022 To 25-08-2022
✔️ SAT quashes insider trading charges against Biocon official Shreehas Tambe
✔️ CBI files charge sheet in Biocon case
-: Stock News :- BIOCON 29-07-2022 To 25-08-2022
✔️ We're geared to launch a new molecule every 1-2 years: Biocon Biologics MD
✔️ CBI files charge sheet in Biocon case
-: Stock News :- BIOCON 15-09-2022 To 15-09-2022
✔️ Bengaluru encroachments: Penalise builders, BBMP, says Kiran Mazumdar-Shaw
-: Stock News :- BIOCON 06-09-2022 To 06-09-2022
✔️ Bengaluru rain havoc: Devastating, says Kiran Mazumdar-Shaw
-: Stock News :- BIOCON 17-10-2022 To 17-10-2022
✔️ Biocon in pact with Japan's Yoshindo to commercialise two biosimilar assets
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
-: Stock News :- BIOCON 12-10-2022 To 17-10-2022
✔️ Biocon falls 12% in 5 days on one major 'deficiency' alert for API unit
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
-: Stock News :- BIOCON 19-09-2022 To 17-10-2022
✔️ Broker's Call: Biocon (Buy)
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
-: Stock News :- BIOCON 15-09-2022 To 17-10-2022
✔️ Bengaluru encroachments: Penalise builders, BBMP, says Kiran Mazumdar-Shaw
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
-: Stock News :- BIOCON 06-09-2022 To 17-10-2022
✔️ Bengaluru rain havoc: Devastating, says Kiran Mazumdar-Shaw
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
-: Stock News :- BIOCON 01-09-2022 To 17-10-2022
✔️ Biocon sheds 4%, hits 52-week low as US FDA issues form 483 for 3 sites
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
-: Stock News :- BIOCON 31-08-2022 To 17-10-2022
✔️ US FDA issues 11 observations each for two sites in Bengaluru: Biocon
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
-: Stock News :- BIOCON 25-08-2022 To 17-10-2022
✔️ CBI files charge sheet in Rs 9 lakh Biocon Biologics bribery case
✔️ CBI files charge sheet in Biocon case
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
-: Stock News :- BIOCON 09-08-2022 To 17-10-2022
✔️ Biocon looks to shore up biosimilar business. Will its investment pay off?
✔️ CBI files charge sheet in Biocon case
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
-: Stock News :- BIOCON 04-08-2022 To 17-10-2022
✔️ SAT quashes insider trading charges against Biocon official Shreehas Tambe
✔️ CBI files charge sheet in Biocon case
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
-: Stock News :- BIOCON 29-07-2022 To 17-10-2022
✔️ We're geared to launch a new molecule every 1-2 years: Biocon Biologics MD
✔️ CBI files charge sheet in Biocon case
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
-: Stock News :- BIOCON 25-10-2022 To 25-10-2022
✔️ I am devastated, will always be guided by John: Biocon chief Kiran Majumdar
✔️ Devastated to lose my husband: Biocon founder Kiran Mazumdar-Shaw
-: Stock News :- BIOCON 24-10-2022 To 24-10-2022
✔️ John Shaw, husband of Biocon chief Kiran Mazumdar Shaw, passes away
✔️ John Shaw, husband of Biocon chief Kiran Mazumdar Shaw, passes away
✔️ John Shaw, former Biocon VC and Kiran Mazumdar-Shaw's husband, passes away
-: Stock News :- BIOCON 30-11-2022 To 29-11-2022
✔️ Buzzing Stocks | Biocon, Inox Green Energy, IDFC and others in news today
✔️ Biocon completes acquisition of Viatris' biosimilars business
✔️ Biocon Biologics completes acquisition of Viatris for over $3 billion
✔️ Biocon Biologics completes acquisition of Viatris' global biosimilars biz
-: Stock News :- BIOCON 24-11-2022 To 29-11-2022
✔️ Hold Biocon; target of Rs 290: ICICI Direct
✔️ Biocon completes acquisition of Viatris' biosimilars business
✔️ Biocon Biologics completes acquisition of Viatris for over $3 billion
✔️ Biocon Biologics completes acquisition of Viatris' global biosimilars biz
-: Stock News :- BIOCON 22-11-2022 To 29-11-2022
✔️ Biocon investors await smooth integration, execution of Viatris deal
✔️ Biocon completes acquisition of Viatris' biosimilars business
✔️ Biocon Biologics completes acquisition of Viatris for over $3 billion
✔️ Biocon Biologics completes acquisition of Viatris' global biosimilars biz
-: Stock News :- BIOCON 21-11-2022 To 29-11-2022
✔️ Buy Biocon; target of Rs 340: Sharekhan
✔️ Biocon completes acquisition of Viatris' biosimilars business
✔️ Biocon Biologics completes acquisition of Viatris for over $3 billion
✔️ Biocon Biologics completes acquisition of Viatris' global biosimilars biz
-: Stock News :- BIOCON 18-11-2022 To 29-11-2022
✔️ Buy Biocon; target of Rs 340: Sharekhan
✔️ Biocon completes acquisition of Viatris' biosimilars business
✔️ Biocon Biologics completes acquisition of Viatris for over $3 billion
✔️ Biocon Biologics completes acquisition of Viatris' global biosimilars biz
-: Stock News :- BIOCON 15-11-2022 To 14-11-2022
✔️ Q2FY23 Quarterly Result Announced for Biocon Ltd.
✔️ Trying to lock in vendors who don't want to buy from China: Biocon CEO & MD
✔️ Biocon's net profits slip 66% to 47 crore in Q2
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 25-10-2022 To 14-11-2022
✔️ I am devastated, will always be guided by John: Biocon chief Kiran Majumdar
✔️ Devastated to lose my husband: Biocon founder Kiran Mazumdar-Shaw
✔️ Biocon's net profits slip 66% to 47 crore in Q2
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 24-10-2022 To 14-11-2022
✔️ John Shaw, husband of Biocon chief Kiran Mazumdar Shaw, passes away
✔️ John Shaw, husband of Biocon chief Kiran Mazumdar Shaw, passes away
✔️ John Shaw, former Biocon VC and Kiran Mazumdar-Shaw's husband, passes away
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 17-10-2022 To 14-11-2022
✔️ Biocon in pact with Japan's Yoshindo to commercialise two biosimilar assets
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 12-10-2022 To 14-11-2022
✔️ Biocon falls 12% in 5 days on one major 'deficiency' alert for API unit
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 19-09-2022 To 14-11-2022
✔️ Broker's Call: Biocon (Buy)
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 15-09-2022 To 14-11-2022
✔️ Bengaluru encroachments: Penalise builders, BBMP, says Kiran Mazumdar-Shaw
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 06-09-2022 To 14-11-2022
✔️ Bengaluru rain havoc: Devastating, says Kiran Mazumdar-Shaw
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 01-09-2022 To 14-11-2022
✔️ Biocon sheds 4%, hits 52-week low as US FDA issues form 483 for 3 sites
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 31-08-2022 To 14-11-2022
✔️ US FDA issues 11 observations each for two sites in Bengaluru: Biocon
✔️ Biocon Biologics enters licensing agreement with Yoshindo of Japan
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 25-08-2022 To 14-11-2022
✔️ CBI files charge sheet in Rs 9 lakh Biocon Biologics bribery case
✔️ CBI files charge sheet in Biocon case
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 09-08-2022 To 14-11-2022
✔️ Biocon looks to shore up biosimilar business. Will its investment pay off?
✔️ CBI files charge sheet in Biocon case
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 04-08-2022 To 14-11-2022
✔️ SAT quashes insider trading charges against Biocon official Shreehas Tambe
✔️ CBI files charge sheet in Biocon case
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 29-07-2022 To 14-11-2022
✔️ We're geared to launch a new molecule every 1-2 years: Biocon Biologics MD
✔️ CBI files charge sheet in Biocon case
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 27-07-2022 To 14-11-2022
✔️ Biocon'sQ1 net profit up by 71 per cent to 144crore
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 21-07-2022 To 14-11-2022
✔️ Biocon receives three US FDA observations on its Telangana plant
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 06-07-2022 To 14-11-2022
✔️ Biocon arm Syngene ends contract with Bioinnovat Research over graft case
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 02-07-2022 To 14-11-2022
✔️ Centre suspends 3 scientists over fake Remdesivir sale in Covid 2nd wave
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 23-06-2022 To 14-11-2022
✔️ Will bribery case impact Biocon's business? Expert weighs in
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 05-12-2022 To 05-12-2022
✔️ Biocon Biologics elevates Shreehas Tambe as managing director, CEO
✔️ Shreehas Tambe appointed as MD & CEO of Biocon Biologics
✔️ Biocon Biologics promotes Shreehas Tambe to MD and CEO
✔️ Biocon Biologics appoints Shreehas Tambe as managing director and CEO
✔️ Biocon Biologics Promotes Shreehas Tambe As The Chief
✔️ Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday
-: Stock News :- BIOCON 30-11-2022 To 05-12-2022
✔️ Buzzing Stocks | Biocon, Inox Green Energy, IDFC and others in news today
✔️ Biocon completes acquisition of Viatris' biosimilars business
✔️ Biocon Biologics completes acquisition of Viatris for over $3 billion
✔️ Biocon Biologics completes acquisition of Viatris' global biosimilars biz
✔️ Biocon Biologics Promotes Shreehas Tambe As The Chief
✔️ Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday
-: Stock News :- BIOCON 24-11-2022 To 05-12-2022
✔️ Hold Biocon; target of Rs 290: ICICI Direct
✔️ Biocon completes acquisition of Viatris' biosimilars business
✔️ Biocon Biologics completes acquisition of Viatris for over $3 billion
✔️ Biocon Biologics completes acquisition of Viatris' global biosimilars biz
✔️ Biocon Biologics Promotes Shreehas Tambe As The Chief
✔️ Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday
-: Stock News :- BIOCON 22-11-2022 To 05-12-2022
✔️ Biocon investors await smooth integration, execution of Viatris deal
✔️ Biocon completes acquisition of Viatris' biosimilars business
✔️ Biocon Biologics completes acquisition of Viatris for over $3 billion
✔️ Biocon Biologics completes acquisition of Viatris' global biosimilars biz
✔️ Biocon Biologics Promotes Shreehas Tambe As The Chief
✔️ Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday
-: Stock News :- BIOCON 21-11-2022 To 05-12-2022
✔️ Buy Biocon; target of Rs 340: Sharekhan
✔️ Biocon completes acquisition of Viatris' biosimilars business
✔️ Biocon Biologics completes acquisition of Viatris for over $3 billion
✔️ Biocon Biologics completes acquisition of Viatris' global biosimilars biz
✔️ Biocon Biologics Promotes Shreehas Tambe As The Chief
✔️ Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday
-: Stock News :- BIOCON 18-11-2022 To 05-12-2022
✔️ Buy Biocon; target of Rs 340: Sharekhan
✔️ Biocon completes acquisition of Viatris' biosimilars business
✔️ Biocon Biologics completes acquisition of Viatris for over $3 billion
✔️ Biocon Biologics completes acquisition of Viatris' global biosimilars biz
✔️ Biocon Biologics Promotes Shreehas Tambe As The Chief
✔️ Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday
-: Stock News :- BIOCON 16-11-2022 To 05-12-2022
✔️ Results Earnings Call for Q2FY23 of Biocon Ltd.
✔️ Biocon completes acquisition of Viatris' biosimilars business
✔️ Biocon Biologics completes acquisition of Viatris for over $3 billion
✔️ Biocon Biologics completes acquisition of Viatris' global biosimilars biz
✔️ Biocon Biologics Promotes Shreehas Tambe As The Chief
✔️ Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday
-: Stock News :- BIOCON 28-07-2022 To 14-11-2022
✔️ Q1FY23 Quarterly Result Announced for Biocon Ltd.
✔️ CBI files charge sheet in Biocon case
✔️ Biocon Biologics inks out-licensing agreement with Yoshindo Inc
✔️ Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y
✔️ Biocon Q2 results: Revenue was recorded at 2384 crore grew by 26%
✔️ Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
✔️ Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%
✔️ Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru
-: Stock News :- BIOCON 09-12-2022 To 09-12-2022
✔️ Podcast: Will Viatris deal inject fresh momentum into Biocon biz?
-: Stock News :- BIOCON 29-12-2022 To 29-12-2022
✔️ Pharma stock down 28% in 2022. Brokerage gives 'Buy' tag as 'stock attractive'
-: Stock News :- BIOCON 23-12-2022 To 23-12-2022
✔️ Mehul Kothari recommends Biocon, Aurobindo Pharma for trading gains
-: Stock News :- BIOCON 22-12-2022 To 22-12-2022
✔️ Trade Spotlight | What should you do with Glenmark Pharma, Biocon, LTIMindtree on Thursday?
-: Stock News :- BIOCON 15-12-2022 To 14-12-2022
✔️ Biocon starts new clinical study to evaluate efficacy of Itolizumab
✔️ Biocon starts clinical study to evaluate efficacy of Itolizumab
✔️ Biocon starts clinical trial of drug meant to treat Ulcerative Colitis in India
-: Stock News :- BIOCON 09-12-2022 To 14-12-2022
✔️ Podcast: Will Viatris deal inject fresh momentum into Biocon biz?
✔️ Biocon starts clinical study to evaluate efficacy of Itolizumab
✔️ Biocon starts clinical trial of drug meant to treat Ulcerative Colitis in India
-: Stock News :- BIOCON 01-02-2023 To 01-02-2023
✔️ Biocon sells 9.96% stake in contract research firm Syngene via open market
-: Stock News :- BIOCON 26-01-2023 To 26-01-2023
✔️ Sudha Murthy awarded with Padma Bhushan, Biocon chief Kiran Mazumdar-Shaw calls her an 'inspiration'
-: Stock News :- BIOCON 18-02-2023 To 18-02-2023
✔️ Biocon recalls 3,665 bottles of antifungal drug in US for failed degradation specifications
-: Stock News :- BIOCON 16-02-2023 To 15-02-2023
✔️ Biocon reports a consolidated net loss of Rs 42 crore in Q3. Here's what analysts say
✔️ Have to keep R&D spends at 12% of revenue: Biocon's Kiran Mazumdar-Shaw
-: Stock News :- BIOCON 15-02-2023 To 15-02-2023
✔️ Q3FY23 Quarterly Result Announced for Biocon Ltd.
✔️ Have to keep R&D spends at 12% of revenue: Biocon's Kiran Mazumdar-Shaw
-: Stock News :- BIOCON 14-02-2023 To 14-02-2023
✔️ Viatris deal-related expenses drag Biocon's Q3 net into Rs 42 cr loss
✔️ Biocon posts net loss of 42 cr, even as net revenue grows 36% in Q3
✔️ Biocon Q3FY23 Earnings: Revenue up 36%, PAT falls 25% YoY
✔️ Biocon Q3 consolidated net loss at Rs 21 crore
-: Stock News :- BIOCON 13-02-2023 To 14-02-2023
✔️ MSCI revision: CG Power, Bank Baroda look bullish on charts; avoid Biocon
✔️ Biocon says USFDA issues CRL for Bevacizumab license application
✔️ Biocon Q3FY23 Earnings: Revenue up 36%, PAT falls 25% YoY
✔️ Biocon Q3 consolidated net loss at Rs 21 crore
-: Stock News :- BIOCON 01-02-2023 To 14-02-2023
✔️ Biocon sells 9.96% stake in contract research firm Syngene via open market
✔️ Biocon says USFDA issues CRL for Bevacizumab license application
✔️ Biocon Q3FY23 Earnings: Revenue up 36%, PAT falls 25% YoY
✔️ Biocon Q3 consolidated net loss at Rs 21 crore
-: Stock News :- BIOCON 26-01-2023 To 14-02-2023
✔️ Sudha Murthy awarded with Padma Bhushan, Biocon chief Kiran Mazumdar-Shaw calls her an 'inspiration'
✔️ Biocon says USFDA issues CRL for Bevacizumab license application
✔️ Biocon Q3FY23 Earnings: Revenue up 36%, PAT falls 25% YoY
✔️ Biocon Q3 consolidated net loss at Rs 21 crore
-: Stock News :- BIOCON 29-12-2022 To 14-02-2023
✔️ Pharma stock down 28% in 2022. Brokerage gives 'Buy' tag as 'stock attractive'
✔️ Biocon says USFDA issues CRL for Bevacizumab license application
✔️ Biocon Q3FY23 Earnings: Revenue up 36%, PAT falls 25% YoY
✔️ Biocon Q3 consolidated net loss at Rs 21 crore
-: Stock News :- BIOCON 23-12-2022 To 14-02-2023
✔️ Mehul Kothari recommends Biocon, Aurobindo Pharma for trading gains
✔️ Biocon says USFDA issues CRL for Bevacizumab license application
✔️ Biocon Q3FY23 Earnings: Revenue up 36%, PAT falls 25% YoY
✔️ Biocon Q3 consolidated net loss at Rs 21 crore
-: Stock News :- BIOCON 22-12-2022 To 14-02-2023
✔️ Trade Spotlight | What should you do with Glenmark Pharma, Biocon, LTIMindtree on Thursday?
✔️ Biocon says USFDA issues CRL for Bevacizumab license application
✔️ Biocon Q3FY23 Earnings: Revenue up 36%, PAT falls 25% YoY
✔️ Biocon Q3 consolidated net loss at Rs 21 crore
-: Stock News :- BIOCON 15-12-2022 To 14-02-2023
✔️ Biocon starts new clinical study to evaluate efficacy of Itolizumab
✔️ Biocon starts clinical study to evaluate efficacy of Itolizumab
✔️ Biocon starts clinical trial of drug meant to treat Ulcerative Colitis in India
✔️ Biocon Q3 consolidated net loss at Rs 21 crore
-: Stock News :- BIOCON 09-12-2022 To 14-02-2023
✔️ Podcast: Will Viatris deal inject fresh momentum into Biocon biz?
✔️ Biocon starts clinical study to evaluate efficacy of Itolizumab
✔️ Biocon starts clinical trial of drug meant to treat Ulcerative Colitis in India
✔️ Biocon Q3 consolidated net loss at Rs 21 crore
-: Stock News :- BIOCON 28-02-2023 To 28-02-2023
✔️ Integrated Core Strategies (Asia) buys Biocon shares worth 185 cr
✔️ Integrated Core Strategies (Asia) buys Biocon shares worth Rs 185 crore
-: Stock News :- BIOCON 27-02-2023 To 28-02-2023
✔️ Buy Biocon; target of Rs 266: Sharekhan
✔️ Integrated Core Strategies (Asia) buys Biocon shares worth Rs 185 crore
-: Stock News :- BIOCON 22-02-2023 To 22-02-2023
✔️ Kotak fund invests Rs 1070 crore in Biocon
✔️ Kotak's alternative investment fund pumps in 1,070 cr in Biocon. Details here
✔️ Kotak Special Situations Fund invests 1,070 crore in Biocon
-: Stock News :- BIOCON 18-02-2023 To 22-02-2023
✔️ Biocon recalls 3,665 bottles of antifungal drug in US for failed degradation specifications
✔️ Kotak's alternative investment fund pumps in 1,070 cr in Biocon. Details here
✔️ Kotak Special Situations Fund invests 1,070 crore in Biocon
-: Stock News :- BIOCON 16-02-2023 To 22-02-2023
✔️ Biocon reports a consolidated net loss of Rs 42 crore in Q3. Here's what analysts say
✔️ Have to keep R&D spends at 12% of revenue: Biocon's Kiran Mazumdar-Shaw
✔️ Kotak Special Situations Fund invests 1,070 crore in Biocon
-: Stock News :- BIOCON 15-02-2023 To 22-02-2023
✔️ Q3FY23 Quarterly Result Announced for Biocon Ltd.
✔️ Have to keep R&D spends at 12% of revenue: Biocon's Kiran Mazumdar-Shaw
✔️ Kotak Special Situations Fund invests 1,070 crore in Biocon
-: Stock News :- BIOCON 18-03-2023 To 17-03-2023
✔️ Ahan-I offloads 1.5% stake in Biocon for 380 cr
✔️ Biocon share down by 9% after stake sale via bulk deals
No More Records...